Tuesday - March 10, 2026

Astrocytoma Market Expected to Witness Substantial Growth by 2034, Driven by Novel Therapeutics and Increased R&D Investments | DelveInsight

The key Astrocytoma companies in the market include – Pfizer Inc., Merck & Co. Inc., Novartis AG, Hoffmann-La Roche Ltd., Amgen Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Denovo Biopharma, Orbus Therapeutics, and Breckenridge, among … Continue reading